This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 10/31/2022
Location: Virtual
Subject: Vaccine Hesitancy and Misinformiaton
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of public health advocacy groups

Event Date: 11/01/2022
Location: Virtual
Subject: Infant Formula Update
FDA Participant/Group: TRISTAN COLONIUS; MARK RAZA;
Non FDA Participant/Group: Eugenia Pierson, Kevin O'Neill (Arnold & Porter); Kyle Hanson, Murray Kessler (Perrigo);

Event Date: 11/01/2022
Location: Virtual
Subject: Vaccine Hesitancy and Misinformation
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of public health advocacy groups

Event Date: 11/01/2022
Location: Washington, DC
Subject: Dinner in Honor of Sir Patrick Vallance, UK Government Chief Scientific Advisor
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, and other invited guests

Event Date: 11/02/2022
Location: Washington, DC
Subject: Clinical and Translational Science Award Program Annual Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, and other registered attendees

Event Date: 11/03/2022
Location: Virtual
Subject: Annual Cocaine, Meth and Stimulant Summit
FDA Participant/Group: MICHELLE ADAMS;
Non FDA Participant/Group: Government, academia, media, industry, and other registered attendees

Event Date: 11/03/2022
Location: Virtual
Subject: Virginia Tech Maury Strauss Distinguished Public Lecture: The Role of Translational Science in Addressing the Decline in Health Status in the U.S.: A Perspective from FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Event Date: 11/04/2022
Location: Chicago, IL
Subject: American Heart Association Scientific Sessions
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 11/01/2022
Location: Virtual
Subject: Regulatory Pathways for Hemp Products, Including Cannabidiol (CBD)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from the Office of the Secretary and Executive Office of the President

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 11/01/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several leaders and staff from the Canadian Food Inspection Agency and Health Canada

Event Date: 11/02/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS;
Non FDA Participant/Group: Brian Olney, Danny Wegman, Dave Corsi, Kathleen O'Donnell, Martha Hilton (Wegmans Food Markets, Inc.);

Event Date: 11/04/2022
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of industry, trade, and retail associations

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 11/04/2022
Location: Virtual
Subject: C-Path / FDA 2022 Annual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Bri Sullivan, Cecile Ollivier, Graham Higson, Huong Huynh, Julie Strzyzewski, Karen Stamm, Kevin B. Perkins, Klaus Romero, Kristen Swingle, Rebecca Yuan, Richard Liwski, Stephen Joel Coons, Sudhir Sivakumaran, Wain Fishburn (Critical Path (C-Path) Institute);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/31/2022
Location: Virtual
Subject: In Vivo Gene Therapy and Genome Editing Summit; FDA Efforts to Advance Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and academia stakeholders

Event Date: 11/02/2022
Location: Virtual
Subject: International Society for Pharmaceutical Engineering; Regulatory Keynote: The Potential Impact of Global Convergence on the Availability of Cell and Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, research, and academia stakeholders

Event Date: 11/02/2022
Location: Virtual
Subject: International Society for Pharmaceutical Engineering; Global Regulatory Town Hall
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, research, and academia stakeholders

Event Date: 11/03/2022
Location: Virtual
Subject: Perinatal Stem Cell Society; Advancing the Development of Safe and Effective Regenerative Medicine Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and academia stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 10/31/2022
Location: Virtual
Subject: Real World Evidence Data Collection
FDA Participant/Group: WILLIAM MAISEL; ANGELA KRUEGER; MARY RITCHEY; BRENDAN O'LEARY; DANIEL CANOS; SONJA FULMER;
Non FDA Participant/Group: Ladd Wiley, Sam Butler, Stirling Martin, Sumit Rana (Epic Systems Corporation);

Event Date: 11/04/2022
Location: Virtual
Subject: Diabetes Technology Meeting; Keynote
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of government, industry, technology developers, and users

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 10/31/2022
Location: Virtual
Subject: Health and Chemicals Coalition Meeting; Food Chemical Safety Work Including Chemical Contaminants and Toxic Elements
FDA Participant/Group: DOUGLAS STEARN; KRISTI MULDOON JACOBS; CONRAD CHOINIERE; PAUL SOUTH; STEVEN MUSSER; STEVE HERMANSKY; REBECCA BUCKNER;
Non FDA Participant/Group: Lisette Van Vliet (Breast Cancer Prevention Partners); Jose Jensen, Sarah Sorscher, Thomas Galligan (Center for Science in the Public Interest); Jaydee Hanson (Center for Food Safety);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 11/01/2022
Location: Virtual
Subject: Update on Premarket Tobacco Product Applications (PMTA) and Non-Tobacco Nicotine (NTN) Enforcement
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Katlin Backfield (US Senate, Health, Education, Labor and Pension (HELP) Staff); Jacquelyn Bolen (US House of Representatives, Energy and Commerce (E&C) Staff);

Event Date: 11/01/2022
Location: Virtual
Subject: American Association for Cancer Research (AACR) Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Representatives from the American Association for Cancer Research (AACR)

Event Date: 11/03/2022
Location: Virtual
Subject: Public Health Law Center (PHLC) Webinar; Future Priorities for Federal Commercial Tobacco Regulation: A Conversation with Dr. Brian King
FDA Participant/Group: N/A
Non FDA Participant/Group: Several Representatives from the Public Health Law Center (PHLC)

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event